# 119-hr-10150: Advancing Botanical Drug Development Act of 2026

119-hr-10150, Advancing Botanical Drug Development Act of 2026, is a 119th Congress bill sponsored by Rep. Boebert, Lauren [R-CO-4] (R-CO); status introduced; PRIA reads it as touching household money (as of 2026-09-03).

- Canonical: https://policyrisk.com/legislation/119-hr-10150
- As of: 2026-09-03
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-hr-10150
- Congress: 119
- Title: Advancing Botanical Drug Development Act of 2026
- Status: introduced
- Introduced: 2026-08-27
- Sponsor: Rep. Boebert, Lauren [R-CO-4] (R-CO)
- Cosponsors: 1
- Policy area: Health
- Touches household money: yes
- Last recorded action: 2026-09-03

## Summary

**market exclusivity for botanical drugs** This bill would create a dedicated pathway to encourage investment in plant-based therapies by granting protected market time for qualifying botanical drugs. It would also require the Secretary to write rules that define which products count as "botanical drugs." - Drug developers: A qualifying botanical drug approved from an application submitted after enactment would get a 12-year period during which no 505(b)(2) or 505(j) application that references it could become effective. - Competitors and follow-on manufacturers: Would be prevented from relying on the approved botanical drug to bring competing products to market for 12 years, delaying lower-cost alternatives. - Patients and clinicians: Aims to spur multi-target, evidence-based botanical therapies by addressing unique manufacturing and development challenges and creating stronger incentives to invest in those products.

## Cosponsors (1)

- Rep. Van Orden, Derrick [R-WI-3] (R-WI), 2026-08-27T00:00:00.000Z

## Provisions PRIA read

- 12-Year Market Protection for Botanical Drugs: benefit, high. If enacted, the bill would give certain FDA-approved botanical drugs a 12-year period of market protection. This protection would apply only to botanical drugs approved from applications submitted after the date the law takes effect. During those 12 years, other FDA applications that reference or r…

## Related bills

- 119-hr-9237: Take Care of America’s Veterans Act
- 119-hr-3151: SHIPS for America Act of 2025
- 119-hr-4669: FEMA Act of 2025
- 119-hr-9298: Stopping Harmful and Outrageous Torts Act
- 119-hr-740: Veterans’ ACCESS Act of 2025
- 119-hres-448: Establishing the Select Committee to Investigate the Cover-Up of President Joseph Robinette Biden, Jr.'s Cognitive and Physical Health Decline.

## Sources
- [119-hr-10150 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-bill/10150)

## Related
- [119-hr-9237: Take Care of America’s Veterans Act](https://policyrisk.com/legislation/119-hr-9237)
- [119-hr-3151: SHIPS for America Act of 2025](https://policyrisk.com/legislation/119-hr-3151)
- [119-hr-4669: FEMA Act of 2025](https://policyrisk.com/legislation/119-hr-4669)
- [119-hr-9298: Stopping Harmful and Outrageous Torts Act](https://policyrisk.com/legislation/119-hr-9298)
- [119-hr-740: Veterans’ ACCESS Act of 2025](https://policyrisk.com/legislation/119-hr-740)
- [119-hres-448: Establishing the Select Committee to Investigate the Cover-Up of President Jose…](https://policyrisk.com/legislation/119-hres-448)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-hr-10150 (as of 2026-09-03).